Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%
Ph phase_1
2
50%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (50.0%)
N/A2 (50.0%)

Trials by Status

unknown125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Quantitative Requirements of Docosahexaenoic Acid for Neural Function in Children With Phenylketonuria

NCT00909012
unknownphase_1

Effect of Buglossoides Oil on Recent Chronic Non-injurious Hip and Knee Pain

NCT03576625
completedphase_1

Effect of Dose of Buglossoides Oil on EPA Accrual and on the Inflammatory Response

NCT02540759
completednot_applicable

Effects of Triacylglycerol Structure on Gut Hormones and Haemostatic Markers

NCT01906359

Clinical Trials (4)

Showing 4 of 4 trials
NCT00909012Not Applicable

Quantitative Requirements of Docosahexaenoic Acid for Neural Function in Children With Phenylketonuria

Completed
NCT03576625Phase 1

Effect of Buglossoides Oil on Recent Chronic Non-injurious Hip and Knee Pain

Unknown
NCT02540759Phase 1

Effect of Dose of Buglossoides Oil on EPA Accrual and on the Inflammatory Response

Completed
NCT01906359Not Applicable

Effects of Triacylglycerol Structure on Gut Hormones and Haemostatic Markers

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4